Related references
Note: Only part of the references are listed.Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma
Malcolm Ranson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
Wen-Jen Hwu et al.
CANCER (2006)
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: A randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group
R Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death
RN Trivedi et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide:: A toxicity with therapeutic implications
YB Su et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas
MF Paz et al.
CLINICAL CANCER RESEARCH (2004)
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma
S Ma et al.
BRITISH JOURNAL OF CANCER (2003)
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma
LM Glode et al.
CANCER (2003)
Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma
WJ Hwu et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inhibition of angiogenesis by non-toxic doses of temozolomide
H Kurzen et al.
ANTI-CANCER DRUGS (2003)
Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model
MR Middleton et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Temozolomide plus thalidomide in patients with advanced melanoma: Results of a dose-finding trial
WJ Hwu et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
MR Middleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
